Hospital
Chongqing University Cancer Hospital重庆大学附属肿瘤医院
At a glance
Published values only, each read from the record this page is built on. The listings behind them are in the section below.
-
National key clinical specialties 4 at evidence level A or B
-
Published research 13 PubMed records we hold for this hospital (the newest twenty per hospital)
-
Registered studies 28 records we hold for this hospital, as registered
Rankings & accreditation
These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.
National key clinical specialties
| Specialty | Batch | Evidence | Source |
|---|---|---|---|
| Traditional Chinese Medicine 中医科 | Not published | Level B | https://www.cqch.cn/sitemap |
| Gynecology 妇科 | 2024 | Level A | https://wsjkw.cq.gov.cn/zwgk_242/fdzdgknr/tzgg/gzgs/202405/t20240515_13209571.html |
| Radiation Oncology 肿瘤放射治疗科 | Not published | Level B | https://www.cqch.cn/sitemap |
| Medical Oncology 肿瘤科 | Not published | Level B | https://www.cqch.cn/sitemap |
4 specialty rows, each carrying its own evidence level.
Each row carries its own evidence level and its own source. Level definitions are on the methodology page.
Values written in Chinese are quoted as published by the source.
Conditions treated here
Conditions this site files under the specialties above. It is a record of the listings, not a recommendation.
For international patients
A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.
Hospital details
- Chinese name
- 重庆大学附属肿瘤医院
- English name
- Chongqing University Cancer Hospital
Values written in Chinese are quoted as published by the source.
The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.
Also known as
- Cancer Hospital of Chongqing University
- Chongqing Cancer Hospital
- Chongqing Cancer Institute
- Chongqing Cancer Center
Evidence for this condition
Selected using official public data sources
-
Colorectal cancer
Published research
- Engineered E. coli biosensor with dual-module sensing and signal amplification for non-invasive detection of fecal bile acid salts in colorectal cancer screening. Analytica chimica acta, 2026
- Total Neoadjuvant Therapy With Long-Course Radiotherapy Versus Chemoradiotherapy in High-Risk Locally Advanced Rectal Cancer (TNTCRT): A Multicenter, Randomized, Phase III Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Breast cancer
Published research
- Systemic inflammation and white matter free water jointly explain chemotherapy-related cognitive decline in breast cancer. Brain, behavior, and immunity, 2026
- A ketogenic enzyme HMGCS2 drives malignant progression in HER2-negative breast cancer via RAB23-mediated β-catenin/TCF signaling and mediates Apatinib resistance. Life sciences, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Lung cancer
Published research
- MELTF Drives Lung Cancer Progression and Angiogenesis via HIF-1α-Mediated Activation of the VEGF Signaling Pathway. Molecular carcinogenesis, 2026
- MTAP deficiency enhances collective metastasis in non-small cell lung cancer via WNT3A methylation. Oncogene, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Liver cancer
Published research
- YAP-mediated mechanotransduction promotes hepatocellular carcinoma progression by targeting ATP1A1/CXCL1 axis. Acta pharmacologica Sinica, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Cervical cancer
National key clinical specialty
- Gynecology (level A) https://wsjkw.cq.gov.cn/zwgk_242/fdzdgknr/tzgg/gzgs/202405/t20240515_13209571.html
Published research
- Stichopus japonicus acidic mucopolysaccharide (SJAMP) exerts the tumor-suppressive activity in cervical cancer by targeting TFAP2A to downregulate CENPW. Cytotechnology, 2026
- Exosomal hnRNPA1-delivered miR-27a-3p inhibits the radiation-induced bystander effect in cervical cancer. Precision radiation oncology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Prostate cancer
Published research
- A Multiplex RT-QPCR Assay of ONECUT2, EZH2, and BRCA2 for the Detection of Clinically Significant Prostate Cancer in Needle Biopsies. Cancers, 2026
- Associations between CT-Based Body Composition and Cardiotoxicity and Overall Survival in Patients with Prostate Cancer. Academic radiology, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Nasopharyngeal carcinoma
National key clinical specialty
- Radiation Oncology (level B) https://www.cqch.cn/sitemap
Published research
- Developing personas for nutritional self-management in nasopharyngeal carcinoma patients: a qualitative study based on the Fogg Behavior Model. Frontiers in nutrition, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Esophageal cancer
Published research
- miR-138-5p suppresses M2 macrophage polarization in esophageal squamous cell carcinoma via exosomes. Cellular signalling, 2026
PubMed indexes 1 paper on this condition that names this hospital.
Also ranked: Medical Oncology nominated in the Fudan list.
-
Pancreatic cancer
Fudan specialty reputation ranking 2023
- Medical Oncology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Medical Oncology (level B) https://www.cqch.cn/sitemap
-
Ovarian cancer
National key clinical specialty
- Gynecology (level A) https://wsjkw.cq.gov.cn/zwgk_242/fdzdgknr/tzgg/gzgs/202405/t20240515_13209571.html
Also ranked: Medical Oncology nominated in the Fudan list.
-
Bone and soft tissue sarcoma
Fudan specialty reputation ranking 2023
- Medical Oncology nominated https://www.fdygs.com/news2023-1.aspx
National key clinical specialty
- Medical Oncology (level B) https://www.cqch.cn/sitemap
Other hospitals in Chongqing
Source & evidence
- Source URL
- https://www.fdygs.com/news2023-1.aspx
- Source scheme
- https
- Source type
- Third-party compilation
- Evidence level
- B - hospital self-statement or authoritative media
- Retrieved on
- 2026-09-24